Skip to main content
Year archive

PERCHERON THERAPEUTICS LIMITED — 2024 filings

All 69 regulatory filings released by PERCHERON THERAPEUTICS LIMITED (PER) in 2024, sourced directly from the official regulator.

69 Filings
2024 Period
2024 filings (69)
Filing Released Lang
Change of Director's Interest Notice-Dr Charmaine Gittleson 2 pages 220.4KB
Director's Dealing
2024-12-30 English
Change of Director's Interest Notice - Dr James Garner 2 pages 221.3KB
Director's Dealing
2024-12-26 English
Notification of cessation of securities - PER 4 pages 15.5KB
Regulatory Filings
2024-12-19 English
Change of Director's Interest Notice-Dr Charmaine Gittleson 2 pages 220.5KB
Director's Dealing
2024-12-19 English
Change in substantial holding 4 pages 172.4KB
Regulatory Filings
2024-12-18 English
Topline Six-Month Results From Phase IIb Study of Avicursen 3 pages 122.5KB
Regulatory Filings
2024-12-17 English
Trading Halt 2 pages 204.6KB
Regulatory Filings
2024-12-15 English
Reorganisation of US Quoted Securities 2 pages 106.4KB
Capital/Financing Update
2024-12-02 English
Resignation of Joint Company Secretary 1 page 99.5K
Board/Management Information
2024-12-01 English
Clinical Trial Update 2 pages 111.7KB
Regulatory Filings
2024-12-01 English
Notification regarding unquoted securities - PER 8 pages 27.3KB
Share Issue/Capital Change
2024-11-28 English
Change of Director's Interest Notice - Dr James Garner 2 pages 221.2KB
Director's Dealing
2024-11-27 English
Notice under S708A 1 page 200.5KB
Capital/Financing Update
2024-11-26 English
Application for quotation of securities - PER 5 pages 16.5KB
Share Issue/Capital Change
2024-11-25 English
Notification regarding unquoted securities - PER 6 pages 20.8KB
Share Issue/Capital Change
2024-11-24 English
Change of Director's Interest Notice Dr James Garner 3 pages 223.4KB
Director's Dealing
2024-11-24 English
Change of Director's Interest Notice - Dr Ben Gil Price 3 pages 223.9KB
Director's Dealing
2024-11-24 English
Withdrawal of Resolutions from the Annual General Meeting 1
AGM Information
2024-11-20 English
Annual General Meeting - Chair's Address 5 pages 177.1KB
AGM Information
2024-11-20 English
Annual General Meeting Management Presentation 22 pages 1.2MB
AGM Information
2024-11-20 English
Results of the Annual General Meeting 2 pages 153.7KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-20 English
Proposed issue of securities - PER 7 pages 27.0KB
Capital/Financing Update
2024-11-20 English
Proposed issue of securities - PER 6 pages 23.7KB
Capital/Financing Update
2024-11-20 English
Change in substantial holding 4 pages 191.5KB
Regulatory Filings
2024-11-14 English
Application for quotation of securities - PER 6 pages 18.2KB
Share Issue/Capital Change
2024-11-13 English
Change of Director's Interest Notice - Dr James Garner 2 pages 212.0KB
Director's Dealing
2024-11-13 English
Results of Share Purchase Plan 2 pages 112.0KB
Capital/Financing Update
2024-11-12 English
Quarterly Activities Report and Appendix 4C 11 pages 464.2KB
Interim / Quarterly Report
2024-10-30 English
Share Purchase Plan Offer Booklet 19 pages 701.2KB
Capital/Financing Update
2024-10-27 English
Percheron launches post-trial access program 2 pages 112.1KB
Regulatory Filings
2024-10-27 English
Notice under S708A 1 page 200.5KB
Share Issue/Capital Change
2024-10-24 English
Application for quotation of securities - PER 5 pages 16.5KB
Share Issue/Capital Change
2024-10-23 English
Update - Proposed issue of securities - PER 5 pages 17.9KB
Capital/Financing Update
2024-10-22 English
Percheron to launch Share Purchase Plan 3 pages 116.3KB
Capital/Financing Update
2024-10-22 English
Proposed issue of securities - PER 6 pages 20.3KB
Capital/Financing Update
2024-10-22 English
Percheron Holds International Advisory Boards 2 pages 130.7KB
Regulatory Filings
2024-10-20 English
$13.0 million Institutional Placement 3 pages 118.2KB
Capital/Financing Update
2024-10-17 English
Proposed issue of securities - PER 5 pages 17.9KB
Capital/Financing Update
2024-10-17 English
Proposed issue of securities - PER 5 pages 18.5KB
Capital/Financing Update
2024-10-17 English
2024 Notice of Annual General Meeting 34 pages 1.9MB
AGM Information
2024-10-17 English
Addendum to 2024 Notice of Annual General Meeting 8 pages 317.6KB
AGM Information
2024-10-17 English
Trading Halt 2 pages 204.2KB
Capital/Financing Update
2024-10-15 English
Percheron Receives $2.35 million R&D Tax Incentive Rebate 1
Capital/Financing Update
2024-10-07 English
Change of Company Auditor 1 page 94.1KB
Regulatory Filings
2024-09-30 English
Completion of avicursen (ATL1102) toxicology study 2 pages 268.8KB
Regulatory Filings
2024-09-29 English
Percheron Therapeutics Limited Corporate Presentation 26 pages 1.9MB
Investor Presentation
2024-09-03 English
ATL1102 Shows Preclinical Activity in Autoimmune Epilepsy 3 pages 157.6KB
Regulatory Filings
2024-09-02 English
Appendix 4E and Annual Report 61 pages 5.5MB
Annual Report
2024-08-28 English
Appendix 4G and Corporate Governance Statement 28 pages 723.6KB
Regulatory Filings
2024-08-28 English
Notice of date of AGM and other relevant dates 1 pa
AGM Information
2024-08-28 English
Quarterly Activities Report and Appendix 4C 10 pages 441.4KB
Interim / Quarterly Report
2024-07-30 English
Notification regarding unquoted securities - PER 7 pages 22.2KB
Share Issue/Capital Change
2024-07-03 English
Deborah Ambrosini appointed as CFO & Company Secretary 2 pages 97.7KB
Board/Management Information
2024-06-16 English
Percheron appoints Dr Cathryn Clary as Chief Medical Advisor 2 pages 94.1KB
Board/Management Information
2024-06-02 English
Percheron to present at 2024 BIO International Convention 22 pages 1.9MB
Investor Presentation
2024-05-30 English
Phase IIb study of ATL1102 in DMD completes recruitment 4 pages 136.6KB
Regulatory Filings
2024-05-28 English
Preliminary Results of 9 Month Toxicology Study of ATL1102 2 pages 117.6KB
Regulatory Filings
2024-05-26 English
US Patent Granted for ATL1102 in Duchenne muscular dystrophy 2 pages 108.4KB
Regulatory Filings
2024-05-19 English
WHO selects proposed INN for ATL1102 3 pages 115.6KB
Regulatory Filings
2024-05-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 411.7KB
Interim / Quarterly Report
2024-04-29 English
Change in substantial holding 6 pages 233.8KB
Regulatory Filings
2024-04-25 English
ATL1102 Clinical Trial Update 2 pages 261.8KB
Regulatory Filings
2024-04-01 English
ATL1102 Data presented at MDA Annual Conference 6 pages 2.2MB
Investor Presentation
2024-03-03 English
Half Yearly Report and Accounts 24 pages 9.8MB
Regulatory Filings
2024-02-27 English
Percheron Therapeutics Limited Corporate Presentation 21 pages 2.0MB
Investor Presentation
2024-02-25 English
Change of Registered Office and Principal Place of Business 2 pages 181.4KB
Regulatory Filings
2024-02-20 English
Receipt of R&D Tax incentive payment 1 page 179.4KB
Regulatory Filings
2024-02-11 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 422.6KB
Interim / Quarterly Report
2024-01-30 English
ATL1102 DMD Phase IIA Final Data Published 4 pages 199.3KB
Regulatory Filings
2024-01-28 English